120 related articles for article (PubMed ID: 18081619)
1. Brief assessment of cognition in schizophrenia: validation of the Japanese version.
Kaneda Y; Sumiyoshi T; Keefe R; Ishimoto Y; Numata S; Ohmori T
Psychiatry Clin Neurosci; 2007 Dec; 61(6):602-9. PubMed ID: 18081619
[TBL] [Abstract][Full Text] [Related]
2. Emotional Intelligence and cognitive abilities - associations and sex differences.
Pardeller S; Frajo-Apor B; Kemmler G; Hofer A
Psychol Health Med; 2017 Sep; 22(8):1001-1010. PubMed ID: 27852112
[TBL] [Abstract][Full Text] [Related]
3. A multicenter, randomized controlled trial of individualized occupational therapy for patients with schizophrenia in Japan.
Shimada T; Ohori M; Inagaki Y; Shimooka Y; Sugimura N; Ishihara I; Yoshida T; Kobayashi M
PLoS One; 2018; 13(4):e0193869. PubMed ID: 29621261
[TBL] [Abstract][Full Text] [Related]
4. Sensitivity and applicability of the Brazilian version of the Brief Assessment of Cognition in Schizophrenia (BACS).
Salgado JV; Carvalhaes CFR; Pires AM; Neves MCLD; Cruz BF; Cardoso CS; Lauar H; Teixeira AL; Keefe RSE
Dement Neuropsychol; 2007; 1(3):260-265. PubMed ID: 29213399
[TBL] [Abstract][Full Text] [Related]
5. Effect of individualized occupational therapy on cognition among patients with schizophrenia: A randomized controlled trial.
Shimada T; Morimoto T; Nagayama H; Nakamura N; Aisu K; Kito A; Kojima R; Yamanushi A; Kawano K; Hikita N; Yotsumoto K; Ebisu T; Kawamura M; Inoue T; Orui J; Asakura T; Akazawa M; Kobayashi M
Schizophr Res; 2024 Jul; 269():18-27. PubMed ID: 38718691
[TBL] [Abstract][Full Text] [Related]
6. Using the Brief Assessment of Cognition in Schizophrenia (BACS) to assess cognitive impairment in older patients with schizophrenia and bipolar disorder.
Cholet J; Sauvaget A; Vanelle JM; Hommet C; Mondon K; Mamet JP; Camus V
Bipolar Disord; 2014 May; 16(3):326-36. PubMed ID: 24383665
[TBL] [Abstract][Full Text] [Related]
7. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
[TBL] [Abstract][Full Text] [Related]
8. Norms and standardization of the Brief Assessment of Cognition in Schizophrenia (BACS).
Keefe RS; Harvey PD; Goldberg TE; Gold JM; Walker TM; Kennel C; Hawkins K
Schizophr Res; 2008 Jul; 102(1-3):108-15. PubMed ID: 18495435
[TBL] [Abstract][Full Text] [Related]
9. The positive and negative syndrome scale (PANSS) for schizophrenia.
Kay SR; Fiszbein A; Opler LA
Schizophr Bull; 1987; 13(2):261-76. PubMed ID: 3616518
[TBL] [Abstract][Full Text] [Related]
10. Establishing the Brief Assessment of Cognition - Short form.
Lam M; Wang M; Huang W; Eng GK; Rapisarda A; Kraus M; Kang S; Keefe RSE; Lee J
J Psychiatr Res; 2017 Oct; 93():1-11. PubMed ID: 28549241
[TBL] [Abstract][Full Text] [Related]
11. Relationships between erythrocyte membrane mono- and poly- unsaturated fatty acid composition and clinical/cognitive indices in antipsychotic-free schizophrenia patients.
Higuchi Y; Takahashi T; Itoh H; Sasabayashi D; Sumiyoshi T; Suzuki M
Front Psychiatry; 2024; 15():1361997. PubMed ID: 38716119
[TBL] [Abstract][Full Text] [Related]
12. Associations among plasma markers for N-methyl-d-aspartate receptor hypofunction, redox dysregulation, and insufficient myelination in patients with schizophrenia.
Isomura Y; Ohno M; Sudo S; Ono M; Kaminishi Y; Sumi Y; Yoshimura A; Fujii K; Akiyama K; Nishi E; Ozeki Y
Heliyon; 2024 May; 10(9):e30193. PubMed ID: 38694089
[TBL] [Abstract][Full Text] [Related]
13. Relationship between personal recovery, autobiographical memory, and clinical recovery in people with mental illness in the acute phase.
Mori T; Hattori R; Irie K; Tsurumi K; Murai T; Ishii R; Inadomi H
Heliyon; 2024 Feb; 10(4):e26075. PubMed ID: 38390044
[TBL] [Abstract][Full Text] [Related]
14. Valuable interaction with cognitive remediation and optimal antipsychotics for recovery in schizophrenia (VICTORY-S): study protocol for an interventional, open-label, randomized comparison of combined treatment with cognitive remediation and lurasidone or paliperidone.
Kubota R; Ikezawa S; Oi H; Oba MS; Izumi S; Tsuno R; Adachi L; Miwa M; Toya S; Nishizato Y; Haga D; Iwane T; Nakagome K
Front Psychiatry; 2023; 14():1331356. PubMed ID: 38380376
[TBL] [Abstract][Full Text] [Related]
15. Aberrant brain dynamics of large-scale functional networks across schizophrenia and mood disorder.
Ishida T; Yamada S; Yasuda K; Uenishi S; Tamaki A; Tabata M; Ikeda N; Takahashi S; Kimoto S
Neuroimage Clin; 2024; 41():103574. PubMed ID: 38346380
[TBL] [Abstract][Full Text] [Related]
16. Associations between negative and positive automatic thoughts and clinical variables in patients with schizophrenia.
Takeda T; Nakataki M; Umehara H; Numata S
Schizophr Res Cogn; 2024 Mar; 35():100298. PubMed ID: 38115993
[TBL] [Abstract][Full Text] [Related]
17. Age-related cognitive decline is accelerated in alcohol use disorder.
Kurihara K; Shiroma A; Koda M; Shinzato H; Takaesu Y; Kondo T
Neuropsychopharmacol Rep; 2023 Dec; 43(4):587-595. PubMed ID: 37926928
[TBL] [Abstract][Full Text] [Related]
18. Electrode montage for transcranial direct current stimulation governs its effect on symptoms and functionality in schizophrenia.
Yamada Y; Narita Z; Inagawa T; Yokoi Y; Hirabayashi N; Shirama A; Sueyoshi K; Sumiyoshi T
Front Psychiatry; 2023; 14():1243859. PubMed ID: 37860168
[TBL] [Abstract][Full Text] [Related]
19. Analysis of polyunsaturated fatty acids in antipsychotic-free individuals with at-risk mental state and patients with first-episode schizophrenia.
Le ATP; Higuchi Y; Sumiyoshi T; Itoh H; Sasabayashi D; Takahashi T; Suzuki M
Front Psychiatry; 2023; 14():1188452. PubMed ID: 37564244
[TBL] [Abstract][Full Text] [Related]
20. Polydipsia and autistic traits in patients with schizophrenia spectrum disorders.
Komatsu H; Ono T; Onouchi Y; Onoguchi G; Maita Y; Ishida Y; Maki T; Oba A; Tomita H; Kakuto Y
Front Psychiatry; 2023; 14():1205138. PubMed ID: 37484674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
